Gomiliximab - CISMeF

Preferred Label : Gomiliximab;

NCIt synonyms : Monoclonal Antibody IDEC-152; p5E8; anti-CD23 Antibody; Lumiliximab; IDEC-152 Monoclonal Antibody;

NCIt definition : IDEC-152 was developed to decrease the body's response to allergens, thereby affecting diseases related to asthma and allergic disorders. This chimeric monoclonal antibody binds to the CD23 receptor, by which IDEC-152 may favorably influence asthma through its selective regulation of IgE production and its inhibition of other inflammatory pathways.;

UNII : 8Z13S29R5A;

CAS number : 357613-86-6;

Details

Origin ID

C26448;

UMLS CUI

C1327944;

Automatic exact mappings (from CISMeF team)
- gomiliximab [MeSH concept]
Currated CISMeF NLP mapping
- lumiliximab [MeSH concept]
- lumiliximab [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- lumiliximab [MeSH Supplementary Concept]
- lumiliximab [MeSH concept]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
has_target
- Low Affinity Immunoglobulin Epsilon Fc Receptor [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients